<DOC>
	<DOCNO>NCT01275521</DOCNO>
	<brief_summary>BPH common elderly men , stromal well epithelial invasion prostatic gland . Due imbalance growth apoptosis cellular mechanism fully elucidate . It symptomatology urodynamic obstruction without clear identification part due static phenomenon ( volume increase ) dynamic report ( α 1-receptor action ) . That explain multiplicity treatment difficulty therapeutic indication monitoring , medical treatment , surgical operation . Experimental study BONT-A intra prostatic injection animal human model , show efficacy BPH cell apoptosis , decrease cell growth decline number adrenergic α1 receptor . Many study human show therapeutic efficacy lead possible use BONT-A mini invasive treatment symptomatic BPH , alternative medical surgical treatment . PROTOX study propose evaluate tolerance effectiveness intra-prostatique BONT-A injection treatment symptomatic BPH .</brief_summary>
	<brief_title>A-botulinic Toxin Symptomatic Benign Prostate Hypertrophy</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Patient age 50 85 ; Obstructive irritative urinary symptomatology link BPH ; Score IPSS moderate severe ( 819 : moderate ; 2035 : severe ) IPSS ≤ 7 patient medically treat symptomatic BPH ; Increase prostate volume rectal touch ultrasound ; Free consent , inform write , date sign patient investigator ( late day inclusion examination require study ) ; Subject affiliate beneficiary social protection stenosis urethra confirm endoscopic radiological examination ; prostate cancer suspicion ; medical past history surgery , radiotherapy pelvic trauma ( , breach urethra , pubic symphysis disjunction ) ; surgical resection prostate ( adenomecty ) ; clinical paraclinical sign vesical sphincterial disynergia ; chronic urinary retention &gt; 500 ml ; BPH complication make surgery necessary : effect upper urinary tract : dilatation renal obstructive insufficiency , bladder stone diverticulum . patient previously treat botulic toxin ( whatever injection site ) ; Persons unable understand course study .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>